1. Home
  2. OMC vs DGX Comparison

OMC vs DGX Comparison

Compare OMC & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omnicom Group Inc.

OMC

Omnicom Group Inc.

HOLD

Current Price

$80.83

Market Cap

14.9B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$184.09

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMC
DGX
Founded
1944
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9B
20.5B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
OMC
DGX
Price
$80.83
$184.09
Analyst Decision
Buy
Buy
Analyst Count
7
15
Target Price
$97.14
$194.07
AVG Volume (30 Days)
6.0M
1.1M
Earning Date
02-03-2026
01-29-2026
Dividend Yield
3.99%
1.75%
EPS Growth
N/A
14.49
EPS
6.79
8.51
Revenue
$16,065,300,000.00
$10,850,000,000.00
Revenue This Year
$4.68
$12.37
Revenue Next Year
$3.44
$3.52
P/E Ratio
$11.83
$21.44
Revenue Growth
4.13
13.74
52 Week Low
$68.37
$148.70
52 Week High
$92.27
$197.55

Technical Indicators

Market Signals
Indicator
OMC
DGX
Relative Strength Index (RSI) 68.53 50.96
Support Level $72.66 $178.61
Resistance Level $74.65 $185.12
Average True Range (ATR) 2.26 2.63
MACD 1.16 -0.46
Stochastic Oscillator 97.32 37.73

Price Performance

Historical Comparison
OMC
DGX

About OMC Omnicom Group Inc.

Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, ad placement, and public relations. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: